Therapeutic Asset Ratings
374 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ag-120
Acute Myeloid Leukemia
French Innovative Leukemia Organisation
P3
B
(61)
ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)
Acute Myeloid Leukemia
Joanna Yi
P3
B
(61)
Rapamycin
Acute Myeloid Leukemia
City of Hope Medical Center
P3
B
(61)
Sorafenib
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P3
B
(61)
Anti-Thymoglobulin, Rabbit
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
P4
B
(60)
cc-5013
Acute Myeloid Leukemia
Medical College of Wisconsin
P4
B
(60)
Clofarabine
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
B
(60)
Inno-206
Acute Myeloid Leukemia
Janssen Research & Development, LLC
P3
B
(60)
(+)-VINCRISTINE
Acute Myeloid Leukemia
Janssen Research & Development, LLC
P3
B
(60)
IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER
Acute Myeloid Leukemia
Actinium Pharmaceuticals
P2
B
(60)
Recombinant Human Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
City of Hope Medical Center
P2
B
(60)
Ruxolitinib
Acute Myeloid Leukemia
Stephan Grupp MD PhD
P4
B
(59)
Bortezomib
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
P3
B
(59)
Enasidenib
Acute Myeloid Leukemia
National Cancer Institute (NCI)
P3
B
(59)
Omacetaxine
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
P3
B
(59)
Astarabine
Acute Myeloid Leukemia
BioSight Ltd.
P2
B
(59)
Plerixafor
Acute Myeloid Leukemia
Washington University School of Medicine
P2
B
(59)
Tucidinostat
Acute Myeloid Leukemia
Dongguan People's Hospital
P2
B
(59)
Panobinostat
Acute Myeloid Leukemia
OHSU Knight Cancer Institute
P4
B
(58)
ASPARAGINASE
Acute Myeloid Leukemia
Sanofi
P3
B
(58)
Bb-Mpi-03
Acute Myeloid Leukemia
Sellas Life Sciences Group
P3
B
(58)
Cedazuridine
Acute Myeloid Leukemia
National Cancer Institute (NCI)
P3
B
(58)
Dasatinib
Acute Myeloid Leukemia
Institut Paoli-Calmettes
P3
B
(58)
Galinpepimut-S
Acute Myeloid Leukemia
Sellas Life Sciences Group
P3
B
(58)
Montanide Isa 51
Acute Myeloid Leukemia
Sellas Life Sciences Group
P3
B
(58)
Showing 51 to 75 of 374 assets
Previous
Page 3 of 15
Next
